TY  - JOUR 
AU  - Fernández Díaz, Cristina María
AU  - Merino Antolín, Beatriz
AU  - López Acosta, José Francisco
AU  - Cidad Velasco, María Del Pilar
AU  - Fuente García, Miguel Ángel de la
AU  - Domínguez Lobatón, María Carmen
AU  - Moreno Díaz-Calderón, Alfredo
AU  - Leissring, Malcolm A.
AU  - Perdomo, Germán
AU  - Cózar Castellano, Irene
PY  - 2019
SN  - 0193-1849
UR  - https://uvadoc.uva.es/handle/10324/74563
AB  - Inhibition of insulin-degrading enzyme (IDE) has been proposed as a possible therapeutic target for type 2 diabetes treatment. However, many aspects of IDE's role in glucose homeostasis need to be clarified. In light of this, new preclinical models...
LA  - spa
TI  - Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity
DO  - 10.1152/ajpendo.00040.2019
ER  -